Charles R. Andrianjara

Statistics

Publications

Citations

120

H-Index

Active since

1999

Affiliations

Pfizer (France)(Current)

Pfizer (United States)

Charles R. Andrianjara is an author at Pfizer (France) specializing in structure-activity relationships, medicinal chemistry, and structure-activity relationship analysis.

Publications per year

1999–2005

Publications

Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors

Anne‐Claude Dublanchet, Pierre Ducrot, Charles R. Andrianjara et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 69 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +14

Synthesis and structure–activity relationships of 4-oxo-1-phenyl-3,4,6,7-tetrahydro-[1,4]diazepino[6,7,1-hi]indoles: novel PDE4 inhibitors

Yves Pascal, Charles R. Andrianjara, Eric Auclair et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Molecular dynamics of NPY Y1 receptor activation

Ingebrigt Sylte, Charles R. Andrianjara, Alain Calvet et al. · Bioorganic & Medicinal Chemistry · 1999 · 15 citations

Life Sciences, Neuroscience, Pharmacology +14

CoMFA and CoMSIA 3D-quantitative structure-activity relationship model on benzodiazepine derivatives, inhibitors of phosphodiesterase IV

Pierre Ducrot, Charles R. Andrianjara, Roger Wrigglesworth · Journal of Computer-Aided Molecular Design · 2001 · 11 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

1–4 of 4